HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duvivier-Kali, V. F. Articles by Weir, G. C. Search for Related Content PubMed PubMed Citation Articles by Duvivier-Kali, V. F. Articles by Weir, G. C. Social Bookmarking                What's this?

Complete Protection of Islets Against Allorejection and Autoimmunity by a Simple Barium-Alginate Membrane

Section of Islet Transplantation and Cell Biology, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, One Joslin Place, Boston, Massachusetts

We describe a new technique for microencapsulation with high–mannuronic acid (high-M) alginate crosslinked with BaCl₂ without a traditional permselective component, which allows the production of biocompatible capsules that allow prolonged survival of syngeneic and allogeneic transplanted islets in diabetic BALB/c and NOD mice for >350 days. The normalization of the glycemia in the transplanted mice was associated with normal glucose profiles in response to intravenous glucose tolerance tests. After explantation of the capsules, all mice became hyperglycemic, demonstrating the efficacy of the encapsulated islets. The retrieved capsules were free of cellular overgrowth and islets responded to glucose stimulation with a 5- to 10-fold increase of insulin secretion. Transfer of splenocytes isolated from transplanted NOD mice to NOD/SCID mice adoptively transferred diabetes, indicating that NOD recipients maintained islet-specific autoimmunity. In conclusion, we have developed a simple technique for microencapsulation that prolongs islet survival without immunosuppression, providing complete protection against allorejection and the recurrence of autoimmune diabetes.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. S. Narang and R. I. Mahato Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243. [Abstract] [Full Text] [PDF]

				Y. H. Choi, J. H. Lee, S. H. Yuk, S. H. Suh, and K.-H. Yoon Core/Shell Macrobeads for the Protection of Islets from Immune System Rejection Journal of Bioactive and Compatible Polymers, January 1, 2006; 21(1): 71 - 81. [Abstract] [PDF]

				S. Schneider, P. J. Feilen, F. Brunnenmeier, T. Minnemann, H. Zimmermann, U. Zimmermann, and M. M. Weber Long-Term Graft Function of Adult Rat and Human Islets Encapsulated in Novel Alginate-Based Microcapsules After Transplantation in Immunocompetent Diabetic Mice Diabetes, March 1, 2005; 54(3): 687 - 693. [Abstract] [Full Text] [PDF]

				L. Makhlouf, A. Yamada, T. Ito, R. Abdi, M. J. I. Ansari, C. Q. Khuong, H. J. Winn, H. Auchincloss Jr., and M. H. Sayegh Allorecognition and Effector Pathways of Islet Allograft Rejection in Normal versus Nonobese Diabetic Mice J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2168 - 2175. [Abstract] [Full Text] [PDF]

				R. Robitaille, J. Dusseault, N. Henley, L. Rosenberg, and J.-P. Halle Insulin-Like Growth Factor II Allows Prolonged Blood Glucose Normalization with a Reduced Islet Cell Mass Transplantation Endocrinology, July 1, 2003; 144(7): 3037 - 3045. [Abstract] [Full Text] [PDF]

				A. Omer, V. F. Duvivier-Kali, N. Trivedi, K. Wilmot, S. Bonner-Weir, and G. C. Weir Survival and Maturation of Microencapsulated Porcine Neonatal Pancreatic Cell Clusters Transplanted into Immunocompetent Diabetic Mice Diabetes, January 1, 2003; 52(1): 69 - 75. [Abstract] [Full Text] [PDF]